Published in J Inherit Metab Dis on January 13, 2009
The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis (2013) 1.07
Large neutral amino acids in the treatment of PKU: from theory to practice. J Inherit Metab Dis (2010) 1.02
Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet J Rare Dis (2013) 0.86
Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice. PLoS One (2015) 0.86
Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model. J Neurochem (2014) 0.84
Oxidative stress in phenylketonuria: future directions. J Inherit Metab Dis (2011) 0.81
Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell Mol Neurobiol (2009) 0.80
Large neutral amino acids supplementation in phenylketonuric patients. J Inherit Metab Dis (2009) 0.80
13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients. Transl Psychiatry (2012) 0.79
Phenylketonuria: brain phenylalanine concentrations relate inversely to cerebral protein synthesis. J Cereb Blood Flow Metab (2014) 0.79
Age-related psychophysiological vulnerability to phenylalanine in phenylketonuria. Front Pediatr (2014) 0.78
Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time. J Inherit Metab Dis (2011) 0.77
Outcomes of phenylketonuria with relevance to follow-up. JIMD Rep (2011) 0.77
Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites. J Inherit Metab Dis (2010) 0.77
Motor development skills of 1- to 4-year-old Iranian children with early treated phenylketonuria. JIMD Rep (2013) 0.77
Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control. J Inherit Metab Dis (2011) 0.76
Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? PLoS One (2014) 0.76
Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia. Front Public Health (2016) 0.75
Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats. Neurochem Res (2015) 0.75
A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria. JIMD Rep (2016) 0.75
Sapropterin hydrochloride: enzyme enhancement therapy for phenylketonuria. Ther Adv Endocrinol Metab (2011) 0.75
The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis (2017) 0.75
Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression. Pteridines (2016) 0.75
Branched-chain and aromatic amino acids in relation to behavioral problems among young Inuit from Nunavik, Canada: a cohort study. Pediatr Res (2017) 0.75
Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem (1971) 2.85
Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem (1987) 2.09
Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci (2002) 2.06
Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol (2006) 1.77
Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet (1999) 1.67
The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res (1972) 1.51
Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol (2001) 1.49
The neurochemistry of phenylketonuria. Eur J Pediatr (2000) 1.39
Amino acid imbalance and intracellular protein synthesis. Nutrition (1993) 1.39
Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res (1998) 1.37
Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest (1999) 1.35
Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev (1990) 1.31
The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Mol Genet Metab (2007) 1.28
Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr (2007) 1.21
A new approach to the treatment of phenylketonuria. J Ment Defic Res (1980) 1.17
Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function. J Inherit Metab Dis (1986) 1.12
Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol (2007) 1.10
Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics (1997) 1.10
Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis (2004) 1.09
Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria. Neuroreport (2000) 1.09
Cerebral protein synthesis in a genetic mouse model of phenylketonuria. Proc Natl Acad Sci U S A (2000) 1.09
Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. J Cereb Blood Flow Metab (1998) 1.09
Cognitive deficits in a genetic mouse model of the most common biochemical cause of human mental retardation. J Neurosci (1999) 1.05
Behaviour in early treated phenylketonuria: a systematic review. Eur J Pediatr (2000) 1.03
Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria. J Int Neuropsychol Soc (2002) 1.03
HYDROXYLATION OF PHENYLALANINE BY PURIFIED PREPARATIONS OF ADRENAL AND BRAIN TYROSINE HYDROXYLASE. Biochem Biophys Res Commun (1965) 1.01
Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J Neurochem (2003) 1.00
Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment. J Inherit Metab Dis (2000) 1.00
The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro. J Neurochem (1976) 0.98
Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis (2000) 0.98
Deficits in memory strategy use related to prefrontal dysfunction during early development: evidence from children with phenylketonuria. Neuropsychology (2001) 0.98
Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia. J Pediatr (1981) 0.96
Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria. Neuroreport (2002) 0.95
An animal model of early-treated PKU. J Neurosci (1994) 0.95
Executive functioning, memory, and learning in phenylketonuria. Neuropsychology (2004) 0.94
Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine. Eur J Pediatr (1988) 0.93
Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab (2005) 0.93
Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child (2006) 0.93
The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance, and maintenance versus manipulation-functions of working memory. Neurosci Biobehav Rev (2002) 0.93
Brain plasticity in paediatric neurology. Eur J Paediatr Neurol (2003) 0.91
Executive functioning and speed of processing in phenylketonuria. Neuropsychology (2005) 0.90
Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol (1982) 0.90
Phenylalanine reduces synaptic density in mixed cortical cultures from mice. Pediatr Res (2006) 0.90
The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria. Behav Genet (2003) 0.89
Evidence for central nervous system glial cell plasticity in phenylketonuria. J Neuropathol Exp Neurol (1996) 0.89
Long-term changes in glutamatergic synaptic transmission in phenylketonuria. Brain (2005) 0.89
Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets. Am J Clin Nutr (2001) 0.88
Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria. Neuropsychology (2003) 0.87
Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: comparison with that on tyrosine hydroxylase activity. Neurosci Lett (2006) 0.86
Deficits in selective and sustained attention processes in early treated children with phenylketonuria--result of impaired frontal lobe functions? Eur J Pediatr (1996) 0.85
Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria. Eur J Pediatr (1996) 0.85
Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy. Pediatr Res (2003) 0.84
Treatable neurotransmitter deficiency in mild phenylketonuria. Neurology (2001) 0.81
Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res (2000) 0.79
Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria. J Inherit Metab Dis (1994) 0.78
Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria. J Inherit Metab Dis (1991) 0.75
Pathogenesis of different clinical outcomes in spite of identical genotypes and comparable blood phenylalanine concentrations in phenylketonurics. J Inherit Metab Dis (1998) 0.75
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res (2013) 2.67
High fat feeding induces hepatic fatty acid elongation in mice. PLoS One (2009) 1.51
Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem (2009) 1.38
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res (2008) 1.28
Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes (2003) 1.28
Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands. J Pediatr (2007) 1.27
The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr (2006) 1.17
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab (2005) 1.16
Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots. Anal Biochem (2003) 1.14
Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice. Hepatology (2010) 1.12
Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci U S A (2010) 1.09
Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol (2013) 1.05
Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice. Hepatology (2008) 1.04
Large neutral amino acids in the treatment of PKU: from theory to practice. J Inherit Metab Dis (2010) 1.02
Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis. Mol Genet Metab (2009) 0.99
An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr-/- mice. J Biol Chem (2009) 0.99
Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients. Mol Genet Metab (2012) 0.99
De novo lipogenesis in the differentiating human adipocyte can provide all fatty acids necessary for maturation. J Lipid Res (2011) 0.97
The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut (2012) 0.96
Biochemical competition makes fatty-acid β-oxidation vulnerable to substrate overload. PLoS Comput Biol (2013) 0.93
Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects. Hum Mol Genet (2013) 0.93
Comparison of amino acid oxidation and urea metabolism in haemodialysis patients during fasting and meal intake. Nephrol Dial Transplant (2004) 0.92
The difference between observed and expected prevalence of MCAD deficiency in The Netherlands: a genetic epidemiological study. Eur J Hum Genet (2005) 0.91
Serum vitamin B12 concentrations within reference values do not exclude functional vitamin B12 deficiency in PKU patients of various ages. Mol Genet Metab (2010) 0.90
Lxralpha deficiency hampers the hepatic adaptive response to fasting in mice. J Biol Chem (2008) 0.87
Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet J Rare Dis (2013) 0.86
Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab (2003) 0.86
Kwashiorkor and marasmus are both associated with impaired glucose clearance related to pancreatic β-cell dysfunction. Metabolism (2012) 0.85
Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study. Orphanet J Rare Dis (2012) 0.85
Chronic prednisolone treatment reduces hepatic insulin sensitivity while perturbing the fed-to-fasting transition in mice. Endocrinology (2010) 0.85
Bile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance rate. PLoS One (2011) 0.83
Mechanisms behind decreased endogenous glucose production in malnourished children. Pediatr Res (2010) 0.83
Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1. Biochem J (2010) 0.82
Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice. Hepatology (2008) 0.82
Lactate disposal via gluconeogenesis is increased during exercise in patients with mitochondrial myopathy due to complex I deficiency. Pediatr Res (2002) 0.81
Gluconeogenesis in humans with induced hyperlactatemia during low-intensity exercise. Am J Physiol Endocrinol Metab (2003) 0.80
In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes. Orphanet J Rare Dis (2013) 0.80
Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to complex I deficiency. Am J Clin Nutr (2002) 0.79
Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I. J Inherit Metab Dis (2010) 0.78
Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Pacing Clin Electrophysiol (2004) 0.78
Postnatal treatment with dexamethasone perturbs hepatic and cardiac energy metabolism and is associated with a sustained atherogenic plasma lipid profile in suckling rats. Pediatr Res (2007) 0.78
Adult patients with well-controlled phenylketonuria tolerate incidental additional intake of phenylalanine. Ann Nutr Metab (2011) 0.77
Protein metabolism in adult patients with phenylketonuria. Nutrition (2007) 0.77
1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU). Eur Radiol (2004) 0.77
Chronic prednisolone treatment aggravates hyperglycemia in mice fed a high-fat diet but does not worsen dietary fat-induced insulin resistance. Endocrinology (2012) 0.76
Triacylglycerol infusion does not improve hyperlactemia in resting patients with mitochondrial myopathy due to complex I deficiency. Am J Clin Nutr (2002) 0.76
Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III? J Hepatol (2007) 0.75
Membrane biocompatibility does not affect whole body protein metabolism during dialysis. Blood Purif (2005) 0.75
Diurnal variations in blood phenylalanine of PKU infants under different feeding regimes. Mol Genet Metab (2011) 0.75
The metabolic response to ingested protein is normal in long-term hemodialysis patients. Am J Kidney Dis (2004) 0.75
Oxidative metabolism appears to be reduced in long-term hemodialysis patients. Am J Kidney Dis (2005) 0.75